LMIRX Mutual Fund

NAV$23.07

Fund Essentials - as of Mar 31, 2026

Net Assets
$3M
Expense Ratio
1.55%
Dividend Yield (Current)
1.33%
Holdings
166
Inception Date
Dec 28, 2006
Fund Family
Franklin Templeton Investments (US)
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+8.01%
1 Year+19.11%
3 Year+17.20%
5 Year+9.94%
10 Year+9.20%

Asset Allocation

Stocks: 98.84%
Cash: 1.16%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
ASML:ASAsml Holding N.V.3.20%
RHHVF:SMRoche Holding Ag-Genussch 2.02%
AZN:LNAstraZeneca PLC2.00%
NOVN:SMNovartis Ag1.99%
HSBA:LNHsbc Securities Inc1.90%
Top 10 Concentration: 17.99%Report Date: Mar 31, 2026
Download all 166 holdings for LMIRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
1.33%
Frequency
Annually
Latest Distribution
$0.84
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how LMIRX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

LMIRX Mutual Fund Overview

LMIRX Mutual Fund (Franklin International Equity Fund Class R) is managed by Franklin Templeton Investments (US) with $3.3M in net assets. LMIRX expense ratio is 1.55%, holding 166 positions across sectors including Unknown, Financials, Consumer Staples. Inception date: 2006-12-28.

LMIRX performance shows a YTD return of 8.01%. The 1-year return is 19.11% and the 5-year return is 9.94%. LMIRX dividend yield stands at 1.33%, paid annually.

LMIRX top holdings include Asml Holding N.V. (3.2%), Roche Holding Ag-Genussch (2.0%), AstraZeneca PLC (2.0%), Novartis Ag (2.0%), Hsbc Securities Inc (1.9%). View all LMIRX holdings, sector breakdown, or dividend history.

LMIRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. LMIRX alternatives are available via the screener, along with tax-loss harvesting opportunities.